| 证券代码 | IMMU.O |
| 证券名称 | Immunomedics Inc |
| 证券类型 | 美股 |
| 上市场所 | 纳斯达克交易所 |
| 上市板块 | - |
| 发行方式 | - |
| 首发上市日 | 1983-11-06 |
| 首发价格(元) | - |
| 首发数量(股) | 0 |
| 首发募资额(元) | - |
| 首发主承销商 | - |
| 货币单位 | USD |
| 公司名称 | Immunomedics, Inc. |
| 注册地址 | 美国特拉华州 |
| 办公地址 | 300 The American Road, Morris Plains, New Jersey, USA |
| 成立日期 | 1982-07 |
| 董事会主席 | - |
| 公司属地 | United States 美国 |
| 公司网址 | www.immunomedics.com |
| 电话 | +1 (973) 605-8200 |
| 传真 | +1 (973) 605-8282 |
| 公司简介 | Immunomedics, Inc. is a clinical-stage biopharmaceutical company developing monoclonal antibody-based products for the targeted treatment of cancer and other serious diseases. Immunomedics’ corporate objective is to become a fully-integrated biopharmaceutical company and a leader in the field of antibody-drug conjugates. |